The QUALITY SYSTEM in Medically Assisted Procreation (MAP) centers aims to ensure the safety, effectiveness and traceability of treatments. These systems are based on specific regulations and international or national standards, such as:
Reference Regulations
- European Directive 2004/23/EC and subsequent amendments: regulates quality and safety in the donation, procurement, testing, processing, preservation, storage and distribution of human cells and tissues.
- Law 40/2004 (Italy): regulates MAR techniques and establishes criteria and limits.
- Guidelines of the National Transplant Center (CNT) and the National MAP Registry (ISS): provide operational guidance.
MAP centers must adopt a Quality Management System (QMS) according to standards such as:
- ISO 9001:2015 – This certification confirms that the center has a quality management system that meets specific international standards. It is the most general quality standard, but it is also applicable to MAR centers.
- ISO 15189:2012 – This certification is specific for medical laboratories, including embryology laboratories in MAR centers. It ensures that the laboratory follows quality and safety standards in diagnostic and therapeutic practices.
- ISO 13485:2016 – This certification concerns medical devices used in MAR treatments (for example instruments for in vitro fertilization, incubators, cryopreservation devices, etc.). It ensures that the center complies with rigorous quality standards for the devices used.
- Good Manufacturing Practices (GMP): good practices for the processing of gametes and embryos, particularly in embryology laboratories.
The key elements of the MAR quality system are:
- Documentation and traceability: every phase of the process must be recorded.
- Risk and non-conformity management.
- Environmental control: monitoring of air and surface quality in laboratories.
- Process validation: freezing techniques, fertilization, embryo culture.
- Continuous staff training.
- Internal and external audits.
Accreditation and certification
In Italy, MPA centers must be authorized and accredited at the regional level and registered with the Italian National Institute of Health.
Each MPA center must have a European Tissue Establishment (TE) compliance certification, which is issued by the National Transplant Center (CNT) in collaboration with the Regions.
This certification confirms that the center complies with the requirements established by Legislative Decrees 191/2007 and 16/2010. The National Transplant Center organizes, together with each individual Region, a periodic verification program of MAR centers (every two years) to certify compliance with the requirements set out in the Legislative Decrees. The program started in 2010 and is conducted jointly with the Regions.
Inspections by the National Transplant Center (CNT) and the Regions are an essential tool to ensure that facilities operate in compliance with current regulations regarding quality, safety and traceability:
CNT Inspections
The CNT is responsible for coordinating, monitoring and supervising the activity of centers that handle human cells and tissues, including MAR centers.
In particular it must:
- Verify compliance with Directive 2004/23/EC and the related Italian implementing decrees.
- Check quality and safety in the processes of manipulation of gametes and embryos.
- Verify the traceability of biological materials.
- Ensure proper risk management and the correct notification of adverse reactions and incidents.
CNT inspectors (often accompanied by regional technicians) examine:
- Documentation (SOPs, registers, certifications).
- Facilities and equipment.
- Laboratory compliance (environment, temperatures, sterility, etc.).
- Interviews with staff
REGIONAL Inspections
Each Region is responsible for authorizing, accrediting and supervising MAR centers within its territory through:
- Compliance with national and regional guidelines.
- Control of facilities, personnel and clinical protocols.
- Verification of healthcare accreditation (presence of minimum structural, technological and organizational requirements).
- Monitoring of activity records and clinical outcomes, to be transmitted annually to the ISS.
During an inspection by the CNT or the Region in a MAR center, a very detailed assessment is carried out regarding the following:
1. Laboratory (embryology, andrology, cryopreservation)
- Controlled environment: contamination class, pressure, temperature, humidity, HEPA filters.
- Maintenance and calibration of incubators, hoods, freezers, centrifuges, etc.
- Process validation: vitrification, insemination, embryo culture.
- Sample traceability: labeling, recording, patient-sample matching.
- Cryopreservation management: nitrogen line, cryocontainer safety, biological material loading/unloading records.
2. Documentation
- Updated and approved Standard Operating Procedures (SOPs).
- Complete and readable laboratory and clinical registers.
- Informed consent forms, correctly signed and updated.
- Incident/adverse effects register (according to European directives).
- Documentation of staff training.
3. Structure and organizational requirements
- Adequacy of premises: separation of sterile areas, clean/dirty pathways.
- Patient safety and privacy.
- Organizational chart, clearly defined roles and responsibilities.
- Presence of a Quality Manager or equivalent.
4. Personnel
- Qualifications and competencies of staff (physicians, embryologists, nursing staff).
- Continuous training, professional updates, CME.
- Authorization to perform healthcare activities according to regional regulations.
5. Safety and risk management
- Procedures for managing adverse events.
- Emergency plans: black-out, technical failures, contaminations.
- Backup systems for data and biological samples.
6. Interviews and observation
Inspectors may interview staff to verify knowledge of SOPs and may directly observe a simulated or real procedure (if authorized).
7. Clinical indicators
- Fertilization, implantation, pregnancy and birth rates.
- Trends of clinical outcomes compared to the national average.
- Correct completion of data in the ISS MAR Registry.
Inspection outcomes
- If everything is compliant, inspectors proceed with the confirmation of authorization/accreditation.
- If non-conformities emerge, the center will receive prescriptions, temporary suspension or, in serious cases, revocation of authorization.
- Non-conformities may be minor (documentation, traceability) or major (risks to patient safety or biological materials).
Conclusions
The quality system in a MAR center is truly fundamental because it ensures that all treatments and procedures are safe, reliable and effective.
A well-structured quality system ensures that every phase, from diagnosis to treatment, is carried out according to high standards, minimizing the risk of errors or complications. Furthermore, it allows continuous monitoring of results, improvement of practices and maintenance of a high level of patient safety. In essence, the quality system helps create a professional and transparent working environment, increasing patient trust and ensuring that the most advanced techniques are applied correctly. It is a key element for providing services of excellence and for the success of medically assisted reproduction treatments.
